Invitae Corp (NVTA)

Trade NVTA now with
1/30/2023 7:33:35 AM Invitae Appoints William H. Osborne To Board Of Directors
1/9/2023 7:07:23 AM Invitae Corp. Q4 Revenue $122 Mln Vs. $126 Mln Last Year
5/19/2022 6:32:07 AM Invitae Announces Commercial Availability Of Expanded Invitae Pharmacogenomics Panel
4/4/2022 6:46:18 AM Invitae Introduces First Comprehensive Genetic Test Suite For Neurodevelopmental Disorders
3/29/2022 6:31:27 AM Invitae Announces Launch Of Invitae Digital Health
3/17/2022 6:34:13 AM Invitae Launches Full Access To Its Liquid-Based Personalized Cancer Monitoring Platform
2/16/2022 3:01:21 AM Invitae Reports Availability Of FusionPlex Dx And LiquidPlex Dx In Europe
1/10/2022 7:01:41 AM Invitae Reports 64% Growth Year-over-year In FY Revenues
10/22/2021 8:07:44 AM Invitae, UCL And Francis Crick Institute Announce New Data From TRACERx Research Collaboration
9/7/2021 7:21:36 AM Invitae To Buy Ciitizen For About $325 Mln